First Vaccine for RSV Receives FDA Approval
The Food and Drug Administration (FDA) has recently given its approval for the first vaccine designed to prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV) in adults aged 60 and older. RSV is a contagious virus that commonly infects the lungs and breathing passages. According to the Centers for Disease Control and …